A Role of Cytochrome P450 in Quinone-Induced Hepatotoxicity

Hepatotoxicity: From Genomics to in vitro and in vivo Models

Volumn , Issue , 2008, Pages 287-297

  Ishihara, Yasuhiro ^a   Shimamoto, Norio ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Animal and plant cells; Antimalarial and antibacterial drugs; Cellular redox homeostasis; Endoplasmic reticulum; Exogenous endogenous oxidative stress; Low molecular mass thiol compounds and protein thiols; Photosynthesis and respiratory chain; Quinone based drugs; Quinone induced hepatotoxicity; Quinones toxic mechanisms

Indexed keywords

EID: 84889435278     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470516751.ch10     Document Type: Chapter

References (42)

1. Arner ES and Holmgren A (2000). Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267: 6102-6109.
2. Asche C (2005). Antitumour quinones. Mini Rev Med Chem 5: 449-467.
3. Barrett WC, DeGnore JP, Konig S, Fales HM, Keng YF, Zhang ZY, Yim MB and Chock PB (1999). Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38: 6699-6705.
4. Bellomo G, Thor H and Orrenius S (1990). Modulation of cellular glutathione and protein thiol status during quinone metabolism. Methods Enzymol 186: 627-635.
5. BerlinVand HaseltineWA(1981). Reduction of adriamycin to a semiquinone-free radical byNADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen. J Biol Chem 256: 4747-4756.
6. Crapo JD, Oury T, Rabouille C, Slot JW and Chang LY (1992). Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc Natl Acad Sci USA 89: 10405-10409.
7. Danson S, Ward TH, Butler J and Ranson M (2004). DT-diaphorase: a target for new anticancer drugs. Cancer Treat Rev 230: 437-449.
8. d'Arcy Doherty M, Rodgers A and Cohen GM (1987). Mechanisms of toxicity of 2-and 5-hydroxy-1,4-naphthoquinone; absence of a role for redox cycling in the toxicity of 2-hydroxy-1,4-naphthoquinone to isolated hepatocytes. J Appl Toxicol 7: 123-129.
9. Droge W (2002). Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95.
10. Fujii J and Ikeda Y (2002). Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 7: 123-130.
11. Galli F, Piroddi M, Annetti C, Aisa C, Floridi E and Floridi A (2005). Oxidative stress and reactive oxygen species. Contrib Nephrol 149: 240-260.
12. Gant TW, Rao DN, Mason RP and Cohen GM (1988). Redox cycling and sulphydryl arylation; their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes. Chem Biol Interact 65: 157-173.
13. Gonzalez FJ (1988). The molecular biology of cytochrome P450s. Pharmacol Rev 40: 243-288.
14. Henderson CJ, Pass GJ and Wolf CR (2006). The hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity. Toxicol Lett 162: 111-117.
15. Henry TR and Wallace KB (1996). Differential mechanisms of cell killing by redox cycling and arylating quinones. Arch Toxicol 70: 482-489.
16. Ishihara Y, Shiba D and Shimamoto N (2006). Enhancement of DMNQ-induced hepatocyte toxicity by cytochrome P450 inhibition. Toxicol Appl Pharmacol 214: 109-117.
17. Imai H and Nakagawa Y (2003). Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med 34: 145-169.
18. Kapitulnik J and StrobelHW(1999). Extrahepatic drug metabolizing enzymes. J Biochem Mol Toxicol 13: 227-230.
19. Kappus H and Sies H (1981). Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia 37: 1233-1241.
20. Keyes SR, Rockwell S and Sartorelli AC (1985). Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. Cancer Res 45: 213-216.
21. Lenzhofer R, Magometschnigg D, Dudczak R, Cerni C, Bolebruch C and Moser K (1983). Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substances. Experientia 39: 62-64.
22. Lown JW (1983). The mechanism of action of quinone antibiotics. Mol Cell Biochem 55: 17-40.
23. McKinnon RA and McManus ME (1996). Localization of cytochromes P450 in human tissues: implications for chemical toxicity. Pathology 28: 148-155.
24. Mates JM (2000). Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153: 83-104.
25. Miller MG, RodgersAand CohenGM(1986). Mechanisms of toxicity of naphthoquinones to isolated hepatocytes. Biochem Pharmacol 35: 1177-1184.
26. Powis G and Appel PL (1980). Relationship of the single-electron reduction potential of quinones to their reduction by flavoproteins. Biochem Pharmacol 29: 2567-2572.
27. Rhee SG, Chae HZ and Kim K (2005). Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552.
28. Ross D and Siegel D (2004). NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol 382: 115-144.
29. Rossi L, Moore GA, Orrenius S and O'Brien PJ (1986). Quinone toxicity in hepatocytes without oxidative stress. Arch Biochem Biophys 251: 25-35.
30. Schmieder PK, Tapper MA, Kolanczyk RC, Hammermeister DE, Sheedy BR and Denny JS (2003). Discriminating redox cycling and arylation pathways of reactive chemical toxicity in trout hepatocytes. Toxicol Sci 72: 66-76.
31. Seung SA, Lee JY, Lee MY, Park JS and Chung JH (1998). The relative importance of oxidative stress versus arylation in the mechanism of quinone-induced cytotoxicity to platelets. Chem Biol Interact 113: 133-144.
32. Tapper MA, Sheedy BR, Hammermeister DE and Schmieder PK (2000). Depletion of cellular protein thiols as an indicator of arylation in isolated trout hepatocytes exposed to 1,4-benzoquinone. Toxicol Sci 55: 327-334.
33. Toxopeus C, van Holsteijn I, Thuring JW, Blaauboer BJ and Noordhoek J (1993). Cytotoxicity of menadione and related quinones in freshly isolated rat hepatocytes: effects on thiol homeostasis and energy charge. Arch Toxicol 67: 674-679.
34. Thomas JP, Maiorino M, Ursini F and Girotti AW(1990). Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. J Biol Chem 265: 454-461.
35. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J Ding, G.J.-F., Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin T, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA and Tocci MJ (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768-774.
36. Thor H, Smith MT, Hartzell P, Bellomo G, Jewell SA and Orrenius S (1982). The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. J Biol Chem 257: 12419-12425.
37. Tsuda H (1990). Role of DT diaphorase the cytotoxicity of menadione and 4-nitroquinoline-1-oxide in cultured mammalian fibroblastic cells. Cancer Lett 55: 195-199.
38. Vennerstrom JL and Eaton JW (1988). Oxidants, oxidant drugs and malaria. J Med Chem 31: 1269-1277.
39. Watanabe N, Dickinson DA, Liu RM and Forman HJ (2004). Quinones and glutathione metabolism. Methods Enzymol 378: 319-340.
40. Wienkers LC and Heath TG (2005). Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov 4: 825-833.
41. Wilkinson GR (2005). Drug metabolism and variability among patients in drug response. N Engl J Med 352: 2211-2221.
42. Wu G, Fang YZ, Yang S, Lupton JR and Turner ND (2004). Glutathione metabolism and its implications for health. J Nutr 134: 489-492.